Latest Isologic News
News, Insight, Education – Welcome to the Isologic Blog
Gallium-68 generator, Galli Eo®
IRE Elit and Isologic announce the approval of the Gallium-68 generator, Galli Eo®, as a drug in Canada December 5th, 2019 - Fleurus, Belgium & Montreal, Canada: IRE ELIT, Belgian radiopharmaceutical company, has just received the Notice of Compliance (NOC) from Health Canada for its drug [...]
I-131 Update June 27, 2019
I-131 capsule and solution production update June 27th, 2019 Dear Valued Customer, We have been informed by our supplier that the last shipment of Sodium Iodide I-131 products (Therapeutics and Diagnostics) to the Canadian market will be June 26th and no production will occur until July 11th. Our [...]
I-131 production update
Iodine-131 Diagnostic and Therapeutic capsule production June 7th, 2019 Dear Customer, We would like to inform you that we received information from our vendor of I-131 that their supplier will be in maintenance for a period of 2 weeks starting June 17th. They are working closely with [...]
Invitation
Invitation Special invitation, Monday June 24, 2019 As part of the SNMMI annual conference to be held from June 22 to June 25, ISOLOGIC invites you to a seminar dedicated to innovative radiopharmaceutical services and the production of PET imaging agents. ****First come first serve**** View invitation [...]
Product Update: I-131 Dx capsule supply
PRODUCT UPDATE - January 10th, 2019 MONTREAL, January 10th, 2019 Dear Customer, We would like to inform you of our I-131 Dx capsule supply. We will have 100 μCi diagnostic capsules available on January 21st. These capsules will have a calibration date of [...]
Product Update
PRODUCT UPDATE - DECEMBER 20th, 2018 MONTREAL, DEC. 20th, 2018 Dear Customer, We would like to inform you that due to an unforeseeable I-131 Dx capsule production issue we will not be able to produce and ship I-131 Dx capsule for an undetermined [...]
General Nuclear Medicine News
News and Education provided by World Leading Experts
First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada
PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC [...]
IRE-ELiT S.A. & Isologic Sign Exclusive Agreement
IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian [...]
ISOLOGIC Acquires Lantheus Canadian Imaging Centres
ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution [...]
Piramal Announces Strategic Partnership with ISOLOGIC
PIRAMAL IMAGING ANNOUNCES STRATEGIC PARTNERSHIP WITH ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS FOR EXCLUSIVE COMMERCIALIZATION OF NEURACEQ IN CANADA BOSTON, June 4, 2015 Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce the companies have entered into a strategic partnership and licensing agreement [...]
Canadian Radiopharmacy Acquisitions
PHARMALOGIC P.E.T. SERVICES OF MONTREAL COMPANY AND CARDINAL HEALTH CANADIAN RADIOPHARMACY ACQUISITIONS March 24th, 2014 IsoLogic is proud to announce that following the acquisitions of Pharmalogic P.E.T. Services of Montreal and Cardinal Health’s Ontario based radiopharmacies, it will operate the combined businesses as [...]